Stockscreener 앱 받기
5.16
2.82%
-0.15
전일 마감가:
$5.31
열려 있는:
$5.23
하루 거래량:
2,153
Relative Volume:
0.09
시가총액:
$192.43M
수익:
$7.80M
순이익/손실:
$-69.02M
주가수익비율:
-2.4098
EPS:
-2.1413
순현금흐름:
$-66.61M
1주 성능:
-3.15%
1개월 성능:
+3.41%
6개월 성능:
-19.06%
1년 성능:
+10.97%
1일 변동 폭
$5.22
$5.23
1주일 범위
$5.22
$5.41
52주 변동 폭
$3.32
$12.70
Molecular Partners Ag Adr Stock (MOLN) Company Profile
MOLN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MOLN
Molecular Partners Ag Adr
|
5.22 | 192.43M | 7.80M | -69.02M | -66.61M | -2.1413 |
|
VRTX
Vertex Pharmaceuticals Inc
|
440.52 | 113.70B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
682.91 | 75.52B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
663.46 | 39.78B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
275.41 | 35.34B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
122.61 | 29.05B | 3.30B | -501.07M | 1.03B | -2.1146 |
Molecular Partners Ag Adr Stock (MOLN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-08-30 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-08-29 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2022-05-25 | 업그레이드 | Credit Suisse | Underperform → Neutral |
| 2022-04-27 | 다운그레이드 | Credit Suisse | Neutral → Underperform |
| 2021-07-13 | 개시 | Cowen | Outperform |
| 2021-07-12 | 재개 | SVB Leerink | Outperform |
모두보기
Molecular Partners Ag Adr 주식(MOLN)의 최신 뉴스
Molecular Partners Outlines Clinical Expansion Plans and Strengthens Radiopharma Strategic Focus for 2025 at 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewswire Inc.
Wall Street Analysts Think Molecular Partners AG Sponsored ADR (MOLN) Could Surge 80.72%: Read This Before Placing a Bet - Yahoo Finance
Here's Why Seagate (STX) is a Strong Momentum Stock - Yahoo Finance
Molecular Partners backs FY24 total expenses view of of CHF 65M-CHF 70M - TipRanks
Molecular Partners, Orano Med announce presentation of MP0712 data - TipRanks
Molecular Partners expands 212Pb co-development agreement with Orano Med - TipRanks
Molecular Partners shares gain on Leerink's outperform rating - Investing.com
Why Sarepta Therapeutics Shares Are Trading Higher By Around 35%; Here Are 20 Stocks Moving Premarket - Benzinga
Molecular Partners Unveils Promising Cancer Therapy - TipRanks
Molecular Partners Shares Rise on Positive Trial Data for MP0317 - MarketWatch
Molecular Partners: Sellers Have Disappeared, Enterprise Value Below Zero (NASDAQ:MOLN) - Seeking Alpha
U.S. shares mixed at close of trade; Dow Jones Industrial Average up 0.19% - Investing.com UK
US stock market gainers for the last week of April 2022 - Nairametrics
Market Data Center - Barron's
Molecular Partners Ag Adr (MOLN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.85%
4.93%
자본화:
|
볼륨(24시간):